Status:
ACTIVE_NOT_RECRUITING
Detect CI (Cognitive Impairment) Study
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cognitive Impairment (CI)
Eligibility:
All Genders
65+ years
Brief Summary
This is a prospective multicenter cohort study which will evaluate rapid (administration time ≤ 5 minutes) cognitive screening tools that can be administered preoperatively in older patients undergoin...
Detailed Description
The primary aims of the study is to (1) determine the diagnostic accuracy (sensitivity, specificity, and the AUC) of two rapid cognitive screening tools (AD8 and Mini-Cog) against the MoCA in the olde...
Eligibility Criteria
Inclusion
- patients ≥ 65 years old;
- competent to provide informed consent in English;
- undergoing elective non-cardiac surgery;
- education ≥ 8 years;
- able to be contacted by telephone.
Exclusion
- previous neurocognitive disorder (e.g., dementia) diagnosis;
- uncontrolled psychiatric disorders;
- hearing and/or vision impairment;
- unable to write or hold pen;
- undergoing neurosurgery;
- unable to provide informed consent.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
383 Patients enrolled
Trial Details
Trial ID
NCT06030765
Start Date
September 15 2023
End Date
December 31 2024
Last Update
August 15 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
399 Bathurst St., Toronto Western Hospital, Dept. of Anesthesia
Toronto, Ontario, Canada, M5T2S8
2
Mount Sinai Hospital
Toronto, Ontario, Canada